Prevalence of Distal Radial Artery Occlusion in Cardiovascular Catheterization Via Distal Radial Access

December 18, 2023 updated by: Wujin People's Hospital

Prevalence of Distal Radial Artery Occlusion (DRAO) in Patients Undergoing Cardiovascular Catheterization Via Distal Radial Access (DRA)

Explore the prevalence of distal radial artery occlusion after cardiac catheterization via distal radial artery and the risk factors

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Cardiac catheterization via distal radial artery is prevalent worldwide, which can reduce the prevalence of radial artery occlusion. However, the distal radial artery occlusion has not been detected. This study is designed to explore the prevalence of distal radial artery occlusion in patients undergoing cardiac catheterization via distal radial access at 1 day and 3 months after the procedure, which is explored by ultrasound. In addition, the risk factors of distal radial artery occlusion are also analyzed.

Study Type

Observational

Enrollment (Actual)

805

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
    • Jiangsu
      • Changzhou, Jiangsu, China, 213017
        • Changzhou Wujin People's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

The subjects consist of patients who present to the cardiac catheterization laboratory for an angiogram or percutaneous intervention for the first time.

Description

Inclusion Criteria:

  • Age ≥ 18 years;
  • Palpable distal radial artery

Exclusion Criteria:

  • Age ≥ 90years;
  • Height≥ 185cm;
  • Cardiogenic shock;
  • Refuse to sign the written informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of distal radial artery occlusion
Time Frame: 3 months after procedure
Prevalence of the distal radial artery occlusion is detected using ultrasound
3 months after procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of distal radial artery occlusion
Time Frame: 1 day after procedure
Prevalence of the distal radial artery occlusion is detected using ultrasound
1 day after procedure
Thickness of distal radial artery
Time Frame: 3 months after procedure
Comparison of the thickness of distal radial artery intima using ultrasound
3 months after procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Wujin People's Hospital

Investigators

  • Study Chair: Gaojun Cai, MD, Cardiovascular department, Changzhou Wujin People's Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2022

Primary Completion (Actual)

December 18, 2023

Study Completion (Actual)

December 18, 2023

Study Registration Dates

First Submitted

March 30, 2022

First Submitted That Met QC Criteria

April 6, 2022

First Posted (Actual)

April 8, 2022

Study Record Updates

Last Update Posted (Estimated)

December 19, 2023

Last Update Submitted That Met QC Criteria

December 18, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CLH20220312

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Complications

Clinical Trials on cardiac catheterization via distal radial artery

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe